ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 184 filers reported holding ACORDA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 4.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $22,000 | -8.3% | 23,517 | +97.2% | 0.00% | – |
Q4 2019 | $24,000 | -77.8% | 11,928 | -68.3% | 0.00% | -100.0% |
Q3 2019 | $108,000 | -83.4% | 37,663 | -55.7% | 0.00% | -83.3% |
Q2 2019 | $652,000 | -65.4% | 84,980 | -40.1% | 0.01% | -80.3% |
Q1 2019 | $1,887,000 | +546.2% | 141,980 | +657.8% | 0.06% | +335.7% |
Q4 2018 | $292,000 | -49.6% | 18,737 | -36.4% | 0.01% | -56.2% |
Q3 2018 | $579,000 | +164.4% | 29,470 | +285.8% | 0.03% | +190.9% |
Q2 2018 | $219,000 | -84.5% | 7,639 | -87.2% | 0.01% | -86.7% |
Q1 2018 | $1,416,000 | +227.0% | 59,878 | +190.3% | 0.08% | +167.7% |
Q1 2017 | $433,000 | +136.6% | 20,627 | +111.5% | 0.03% | +106.7% |
Q4 2016 | $183,000 | +19.6% | 9,752 | +33.2% | 0.02% | +50.0% |
Q3 2016 | $153,000 | -53.1% | 7,323 | -42.7% | 0.01% | -47.4% |
Q2 2016 | $326,000 | -18.1% | 12,775 | -15.1% | 0.02% | -17.4% |
Q1 2016 | $398,000 | -73.6% | 15,051 | -57.3% | 0.02% | -73.9% |
Q4 2015 | $1,507,000 | +115.6% | 35,222 | +33.7% | 0.09% | +151.4% |
Q3 2015 | $699,000 | +153.3% | 26,353 | +218.5% | 0.04% | +169.2% |
Q2 2015 | $276,000 | -73.9% | 8,273 | -74.0% | 0.01% | -75.0% |
Q1 2015 | $1,058,000 | +645.1% | 31,786 | +816.0% | 0.05% | +550.0% |
Q4 2014 | $142,000 | -66.3% | 3,470 | -72.1% | 0.01% | -69.2% |
Q3 2014 | $421,000 | +146.2% | 12,431 | +144.6% | 0.03% | +160.0% |
Q2 2014 | $171,000 | – | 5,083 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |
JNBA Financial Advisors | 1 | $0 | 0.00% |